Galderma raises full-year outlook after sales beat, commits to US expansion
By Reuters Published October 23, 2025 Switzerland’s Galderma raised its full-year guidance on Thursday after third-quarter sales beat expectations despite pressure from US tariffs, sending shares in the skincare company up around 7%.Third-quarter net sales came in at $1.29 billion compared with the $1.24 billion provided in a company-compiled consensus. Cetaphil, Alastin and Restylane skin…


